US drugmaker Pfizer has signed a deal with Germany's BioNTech SE to co-develop a potential vaccine for the coronavirus. The drugmakers will start the collaboration immediately and have signed a letter of intent for the vaccine's distribution outside China, they said in a joint statement.
The companies said they will finalise financial terms, and details regarding development, manufacturing and potential commercialisation of the vaccine over the next few weeks.
On Sunday it was reported that the German government was trying to stop the US from persuading CureVac, another German drugmaker working on an experimental vaccine for the coronavirus, to move its research to the United States.